These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 16416742)
1. Proteomic profiling of mature CD10+ B-cell lymphomas. Fan G; Molstad M; Braziel RM; Standley M; Huang J; Rodgers W; Nagalla S Am J Clin Pathol; 2005 Dec; 124(6):920-9. PubMed ID: 16416742 [TBL] [Abstract][Full Text] [Related]
2. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731 [TBL] [Abstract][Full Text] [Related]
3. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
4. SELDI-TOF plasma profiles distinguish individuals in a protein C-deficient family with thrombotic episodes occurring before age 40. Svensson AM; Whiteley GR; Callas PW; Bovill EG Thromb Haemost; 2006 Dec; 96(6):725-30. PubMed ID: 17139365 [TBL] [Abstract][Full Text] [Related]
5. Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions. Okamoto A; Yamamoto H; Imai A; Hatakeyama S; Iwabuchi I; Yoneyama T; Hashimoto Y; Koie T; Kamimura N; Mori K; Yamaya K; Ohyama C Oncol Rep; 2009 Jan; 21(1):73-9. PubMed ID: 19082445 [TBL] [Abstract][Full Text] [Related]
6. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology]. Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841 [TBL] [Abstract][Full Text] [Related]
7. Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-alpha on renal cell carcinoma cell lines by protein biochip technology. Nakamura K; Yoshikawa K; Yamada Y; Saga S; Aoki S; Taki T; Tobiume M; Shimazui T; Akaza H; Honda N Int J Oncol; 2006 Apr; 28(4):965-70. PubMed ID: 16525647 [TBL] [Abstract][Full Text] [Related]
8. The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas. Wu JM; Borowitz MJ; Weir EG Am J Clin Pathol; 2006 Jul; 126(1):39-46. PubMed ID: 16753591 [TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF. Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244 [TBL] [Abstract][Full Text] [Related]
10. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Novikova SI; He F; Cutrufello NJ; Lidow MS Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361 [TBL] [Abstract][Full Text] [Related]
11. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459 [TBL] [Abstract][Full Text] [Related]
12. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry]. Zhang GQ; Du J; Pang D Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606 [TBL] [Abstract][Full Text] [Related]
13. Comparative proteomic profiling of 2 muscles from 5 different pure pig breeds using surface-enhanced laser desorption/ionization time-of-flight proteomics technology. Mach N; Keuning E; Kruijt L; Hortós M; Arnau J; Te Pas MF J Anim Sci; 2010 Apr; 88(4):1522-34. PubMed ID: 20023129 [TBL] [Abstract][Full Text] [Related]
14. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma. Geng X; Wang F; Li YG; Zhu GP; Zhang WM J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545 [TBL] [Abstract][Full Text] [Related]
15. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors. Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659 [TBL] [Abstract][Full Text] [Related]
16. Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry. Gaines PJ; Powell TD; Walmsley SJ; Estredge KL; Wisnewski N; Stinchcomb DT; Withrow SJ; Lana SE Am J Vet Res; 2007 Apr; 68(4):405-10. PubMed ID: 17397297 [TBL] [Abstract][Full Text] [Related]
17. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472 [TBL] [Abstract][Full Text] [Related]
18. Protein profiling in pathology: analysis and evaluation of 239 frozen tissue biopsies for diagnosis of B-cell lymphomas. Jansen C; Feuth T; Raemaekers JM; Rijntjes J; Meijer JW; Westenend PJ; van Baarlen J; van Krieken JH; Hebeda KM; Groenen PJ Proteomics Clin Appl; 2010 May; 4(5):519-27. PubMed ID: 21137069 [TBL] [Abstract][Full Text] [Related]
19. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS). O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431 [TBL] [Abstract][Full Text] [Related]
20. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis. Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]